Generate Biomedicines, Inc. (GENB)
13.12
+0.03
(+0.23%)
USD |
NASDAQ |
May 29, 16:00
13.13
+0.01
(+0.08%)
After-Hours: 20:00
Generate Biomedicines Market Cap : 1.682B for May 29, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Intellia Therapeutics, Inc. | 1.966B |
| Beam Therapeutics, Inc. | 3.388B |
| Arrowhead Pharmaceuticals, Inc. | 10.97B |
| Oncolytics Biotech, Inc. | 124.13M |
| Sangamo Therapeutics, Inc. | 90.19M |
Market Cap Related Metrics
| Price to Book Value | 3.267 |
| Price | 13.12 |
| Earnings Yield | -16.43% |